Context: The maternal mortality rate in Guinea remains high at 550/100,000 live births. Contraceptive prevalence is still low with 11% for women in union, unmet need was 22% with a fertility rate of 4.8. With this in mind, the DMPA-SC was introduced in Guinea in 2018 and then scaled up to 2020. The objective was to study the supply of DMPA- SC and AI services in the health districts of Conakry in the time of COVID-19. Methods: This was a descriptive, cross-sectional, prospective recruitment study, from March 1 to November 30, 2021 in public health facilities and from June 1 to November 30, 2021 in private health facilities; it involved new users of DMPA SC and AI in these facilities, the review and validation of FP data from the facilities, and post-training follow-up was carried out by telephone or in person. The data were collected in a whatsAPP platform and processed using Excel software. Results: We counted 2279 new users, including 1474 for DMPA-SC and 271 DMPA-SC AI in 28 public health facilities and 383 DMPA-SC and 151DPMA-SC AI in 30 private clinics. The practice of self-injection was more dominant in private clinics (70%) than in public facilities (36%). Conclusion: Private clinics appear to be an opportunity to increase contraceptive prevalence in Guinea.
Published in | Journal of Gynecology and Obstetrics (Volume 10, Issue 3) |
DOI | 10.11648/j.jgo.20221003.12 |
Page(s) | 167-170 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2022. Published by Science Publishing Group |
Introduction, DMPA-SC, Self-injection Conakry, COVID-19
[1] | Spieler J. Sayana® Press: can it be a “game changer” for reducing unmet need for family planning? Contraception 2014; 89: 335–8. |
[2] | EDS Guinée et Enquête MICS – 2018. |
[3] | Burke H, Mueller MP, Perry B, Packer C, Bufumbo L, Mbengue D, et al. Observational study of the acceptability of Sayana among intramuscular DMPA users in Uganda and Senegal. Contraception 2014; 89: 361-7. |
[4] | Keith B, Wood S, Tifft S, Hutchings J. Sayana® Press Home Delivery: Review and Needs Assessment in Low Income Settings Contraception 2014; 89: 344–51. |
[5] | Keith B, Wood S, Chapman C, Alemu E. Perceptions of home and self-injection of Sayana® Press in Ethiopia: a qualitative study. Contraception 2014; 89: 379–84. |
[6] | Information regarding the use of medroxyprogesterone acetate subcutaneous depot during the 2019 novel coronavirus public health emergency. https://www.dhcs.ca.gov/Documents/COVID-19:Medi-Cal-FFS-Depo-Provera-SQ-Temp-Policy.pdf (dernier accès le 22 mai 2020). |
[7] | Jane T. Bertrand, Dieudonné Bidashimwa, Paul bakutuvwidi Makani, Julie H. Hernandez, Pierre Akilimali, Arsène Binanga et al. An observational study to test the acceptability and feasibility of using medical and nursing students to teach clients DMPA self-injection at the community level in Kinshasa. Contraception 2018; 98: 411–17. |
[8] | Cover J, Namagembe A, Tumuslime J, Lim J, Drake J, Mbonye A. A prospective cohortstudy of the feasibility and acceptability of depot medroxyprogesterone acetate (DMPA) administered subcutaeouslythrough self injection. Contraception 2017; 95 (3): 306-11. |
[9] | Sayana Press Self-injection instructions, http://sites.path.org/rh/p436; 2015. |
[10] | Tishina Okegbe, Jean Affo, Florence Djihoun, Aleis Zannou, Odilon Hounyo, Gaston Ahounou, Karamatou Adegnika Bangbola, Nancy Harris et al, Introduction of community-based delivery of medroxyprogesterone acetate subcutaneous depot (DMPA-SC) in Benin: programmatic results. GLOBAL HEALTH: SCIENCE AND PRATICE 2019 (Tome 7) numéro 2: 228-39. |
[11] | Michée Katz, Rebecca L. Newmark, Alison Aronstam, Niamh O’Grady, Sara Strome, Sally Rafié, Jennifer Karlin et al. An implementation project to expand access to self-administered medroxyprogesterone acetate (DMPA) Contraception 2020; 102: 392–95. |
APA Style
Soumah Aboubacar Fode Momo, Moussa Kantara Camara, Ibrahima Koussy Bah, Conte Ibrahima, Sylla Ibrahima. (2022). Introduction of DMPA-SC and Self-injection (AI) in the City of Conakry (Guinea) in Time of COVID-19 in 2021. Journal of Gynecology and Obstetrics, 10(3), 167-170. https://doi.org/10.11648/j.jgo.20221003.12
ACS Style
Soumah Aboubacar Fode Momo; Moussa Kantara Camara; Ibrahima Koussy Bah; Conte Ibrahima; Sylla Ibrahima. Introduction of DMPA-SC and Self-injection (AI) in the City of Conakry (Guinea) in Time of COVID-19 in 2021. J. Gynecol. Obstet. 2022, 10(3), 167-170. doi: 10.11648/j.jgo.20221003.12
AMA Style
Soumah Aboubacar Fode Momo, Moussa Kantara Camara, Ibrahima Koussy Bah, Conte Ibrahima, Sylla Ibrahima. Introduction of DMPA-SC and Self-injection (AI) in the City of Conakry (Guinea) in Time of COVID-19 in 2021. J Gynecol Obstet. 2022;10(3):167-170. doi: 10.11648/j.jgo.20221003.12
@article{10.11648/j.jgo.20221003.12, author = {Soumah Aboubacar Fode Momo and Moussa Kantara Camara and Ibrahima Koussy Bah and Conte Ibrahima and Sylla Ibrahima}, title = {Introduction of DMPA-SC and Self-injection (AI) in the City of Conakry (Guinea) in Time of COVID-19 in 2021}, journal = {Journal of Gynecology and Obstetrics}, volume = {10}, number = {3}, pages = {167-170}, doi = {10.11648/j.jgo.20221003.12}, url = {https://doi.org/10.11648/j.jgo.20221003.12}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jgo.20221003.12}, abstract = {Context: The maternal mortality rate in Guinea remains high at 550/100,000 live births. Contraceptive prevalence is still low with 11% for women in union, unmet need was 22% with a fertility rate of 4.8. With this in mind, the DMPA-SC was introduced in Guinea in 2018 and then scaled up to 2020. The objective was to study the supply of DMPA- SC and AI services in the health districts of Conakry in the time of COVID-19. Methods: This was a descriptive, cross-sectional, prospective recruitment study, from March 1 to November 30, 2021 in public health facilities and from June 1 to November 30, 2021 in private health facilities; it involved new users of DMPA SC and AI in these facilities, the review and validation of FP data from the facilities, and post-training follow-up was carried out by telephone or in person. The data were collected in a whatsAPP platform and processed using Excel software. Results: We counted 2279 new users, including 1474 for DMPA-SC and 271 DMPA-SC AI in 28 public health facilities and 383 DMPA-SC and 151DPMA-SC AI in 30 private clinics. The practice of self-injection was more dominant in private clinics (70%) than in public facilities (36%). Conclusion: Private clinics appear to be an opportunity to increase contraceptive prevalence in Guinea.}, year = {2022} }
TY - JOUR T1 - Introduction of DMPA-SC and Self-injection (AI) in the City of Conakry (Guinea) in Time of COVID-19 in 2021 AU - Soumah Aboubacar Fode Momo AU - Moussa Kantara Camara AU - Ibrahima Koussy Bah AU - Conte Ibrahima AU - Sylla Ibrahima Y1 - 2022/06/30 PY - 2022 N1 - https://doi.org/10.11648/j.jgo.20221003.12 DO - 10.11648/j.jgo.20221003.12 T2 - Journal of Gynecology and Obstetrics JF - Journal of Gynecology and Obstetrics JO - Journal of Gynecology and Obstetrics SP - 167 EP - 170 PB - Science Publishing Group SN - 2376-7820 UR - https://doi.org/10.11648/j.jgo.20221003.12 AB - Context: The maternal mortality rate in Guinea remains high at 550/100,000 live births. Contraceptive prevalence is still low with 11% for women in union, unmet need was 22% with a fertility rate of 4.8. With this in mind, the DMPA-SC was introduced in Guinea in 2018 and then scaled up to 2020. The objective was to study the supply of DMPA- SC and AI services in the health districts of Conakry in the time of COVID-19. Methods: This was a descriptive, cross-sectional, prospective recruitment study, from March 1 to November 30, 2021 in public health facilities and from June 1 to November 30, 2021 in private health facilities; it involved new users of DMPA SC and AI in these facilities, the review and validation of FP data from the facilities, and post-training follow-up was carried out by telephone or in person. The data were collected in a whatsAPP platform and processed using Excel software. Results: We counted 2279 new users, including 1474 for DMPA-SC and 271 DMPA-SC AI in 28 public health facilities and 383 DMPA-SC and 151DPMA-SC AI in 30 private clinics. The practice of self-injection was more dominant in private clinics (70%) than in public facilities (36%). Conclusion: Private clinics appear to be an opportunity to increase contraceptive prevalence in Guinea. VL - 10 IS - 3 ER -